AAAAAA
Results:
1-15
|
Results: 15
Authors:
Schilling, T
Burck, J
Sinn, HP
Clemens, A
Otto, HF
Hoppner, W
Herfarth, C
Ziegler, R
Schwab, M
Raue, F
Citation: T. Schilling et al., Prognostic value of codon 918 (ATG -> ACG) RET proto-oncogene mutations insporadic medullary thyroid carcinoma, INT J CANC, 95(1), 2001, pp. 62-66
Authors:
Raue, F
Citation: F. Raue, Diagnosis of medullary thyroid cancer, THYROID CANCER, 2001, pp. 239-249
Authors:
Raue, F
Citation: F. Raue, Hyper- and hypocalcaemia. Part 2: Hypocalcaemia, DEUT MED WO, 125(22), 2000, pp. 701-702
Authors:
Raue, F
Citation: F. Raue, Hyper- and hypocalcaemia. Part I: Hypercalcaemia, DEUT MED WO, 125(21), 2000, pp. 667-670
Authors:
Raue, F
Citation: F. Raue, Asymptomatic primary hyperparathyroidism - need to treat?, EXP CL E D, 108(4), 2000, pp. 247-248
Authors:
Fassbender, WJ
Krohn-Grimberghe, B
Gortz, B
Litzlbauer, D
Stracke, H
Raue, F
Kaiser, HE
Citation: Wj. Fassbender et al., Multiple endocrine neoplasia (MEN) - An overview and case report - Patientwith sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus, ANTICANC R, 20(6C), 2000, pp. 4877-4887
Authors:
Fischer, M
Raue, F
Citation: M. Fischer et F. Raue, Measurements of bone mineral density - Mineral density in metabolic bone disease, Q J NUCL M, 43(3), 1999, pp. 233-240
Authors:
Behr, TM
Behe, M
Angerstein, C
Gratz, S
Mach, R
Hagemann, L
Jenner, N
Stiehler, M
Frank-Raue, K
Raue, F
Becker, W
Citation: Tm. Behr et al., Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential, CLIN CANC R, 5(10), 1999, pp. 3124S-3138S
Authors:
Raue, F
Ehrenstein, GW
Citation: F. Raue et Gw. Ehrenstein, Characterization of the dynamic properties of binary polypropylene blends via the hysteresis measurement method, MACRO SYMP, 148, 1999, pp. 229-240
Authors:
Gimm, O
Neuberg, DS
Marsh, DJ
Dahia, PLM
Cuong, HV
Raue, F
Hinze, R
Dralle, H
Eng, C
Citation: O. Gimm et al., Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation, ONCOGENE, 18(6), 1999, pp. 1369-1373
Authors:
Behr, TM
Jenner, N
Behe, M
Angerstein, C
Gratz, S
Raue, F
Becker, W
Citation: Tm. Behr et al., Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors, J NUCL MED, 40(6), 1999, pp. 1029-1044
Authors:
Raue, F
Ehrenstein, GW
Citation: F. Raue et Gw. Ehrenstein, Comparison of dynamically loaded PP/EPDM- and PP/mPE-blends using the hysteresis measurement method, J ELASTOM P, 31(3), 1999, pp. 194-204
Authors:
Raue, F
Citation: F. Raue, Bisphosphonates - A new treatment principle in calcium and bone metabolismdisorders, INTERNIST, 40(4), 1999, pp. 448-455
Authors:
Raue, F
Citation: F. Raue, Bisphosphonate. A new therapy principle in calcium and bone metabolic diseases, GYNAKOLOGE, 32(11), 1999, pp. 902-909
Authors:
Eng, C
Thomas, GA
Neuberg, DS
Mulligan, LM
Healey, CS
Houghton, C
Frilling, A
Raue, F
Williams, ED
Ponder, BAJ
Citation: C. Eng et al., Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma, J CLIN END, 83(12), 1998, pp. 4310-4313
Risultati:
1-15
|